Statins 'may curb prostate cancer', suggests lab trial
Cholesterol-lowering statins may curb the spread of prostate cancer by interfering with the ability of tumour cells to squeeze into bones, UK research has shown.
Get unlimited access
As a subscriber you will benefit from:
- Full online and mobile access to news and opinion stories
- Customised email alerts straight to your inbox (30+ alerts available)
- 4,500 practice articles in our archive
- Over £500 worth of CPD learning units